| A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects (NCT05238701) | Luye Pharma Group Ltd. | 2022-02-25 |
| Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates (NCT03495024) | Corporal Michael J. Crescenz VA Medical Center | 2019-01-01 |
| Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia (NCT03287778) | University of North Carolina, Chapel Hill | 2017-12-01 |
| Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia (NCT03254186) | Emory University | 2017-09-18 |
| Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia (NCT03497013) | Suzhou Psychiatric Hospital | 2017-07-31 |
| Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia (NCT03176771) | Tanabe Pharma Corporation | 2017-06-21 |
| Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents (NCT03062033) | Neurocrine Biosciences | 2017-04-04 |
| Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia. (NCT02840760) | Shanghai Mental Health Center | 2016-09-01 |
| Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia (NCT02736955) | Neurocrine Biosciences | 2016-06-13 |
| Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia (NCT02524886) | GGZ Centraal | 2015-06-01 |
| ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders (NCT02252380) | InSightec | 2015-05-01 |
| Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia (NCT02405091) | Neurocrine Biosciences | 2015-03-01 |
| Addressing Involuntary Movements in Tardive Dyskinesia (NCT02291861) | Auspex Pharmaceuticals, Inc. | 2014-10-31 |
| Reducing Involuntary Movements in Participants With Tardive Dyskinesia (NCT02198794) | Auspex Pharmaceuticals, Inc. | 2014-10-20 |
| A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia (NCT02274558) | Neurocrine Biosciences | 2014-10-01 |
| Aim to Reduce Movements in Tardive Dyskinesia (NCT02195700) | Auspex Pharmaceuticals, Inc. | 2014-06-01 |
| D-Serine Treatment For Tardive Dyskinesia (NCT01804920) | Herzog Hospital | 2013-01-01 |
| NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia (NCT01733121) | Neurocrine Biosciences | 2012-12-01 |
| NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study) (NCT01688037) | Neurocrine Biosciences | 2012-09-01 |
| Xenazine in Late Dyskinetic Syndrome With Neuroleptics (NCT01543321) | Centre Hospitalier Universitaire, Amiens | 2012-05-14 |
| The Assessment of Movement Disorders Utilizing Live Two-Way Video (NCT01467089) | Northwell Health | 2011-11-01 |
| NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (NCT01393600) | Neurocrine Biosciences | 2011-08-01 |
| Pyridoxal Kinase Activity in Tardive Dyskinesia (NCT01908452) | Beersheva Mental Health Center | 2011-07-01 |
| Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia (NCT01267188) | Neurocrine Biosciences | 2011-01-01 |
| Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia (NCT00917293) | Medicure | 2009-05-01 |
| Melatonin Treatment for Tardive Dyskinesia in Schizophrenia (NCT01391390) | Beijing HuiLongGuan Hospital | 2008-09-01 |
| Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia (NCT00621634) | Université de Montréal | 2008-02-01 |
| Extract of Ginkgo Biloba and Tardive Dyskinesia (NCT00672373) | Beijing HuiLongGuan Hospital | 2006-12-01 |
| Piracetam for Treatment Tardive Dyskinesia (NCT00190008) | Beersheva Mental Health Center | 2003-08-01 |
| Tardive Dyskinesia and Cognitive Function (NCT00926965) | Taipei Veterans General Hospital, Taiwan | 2003-01-01 |
| Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia (NCT00401089) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2002-12-01 |
| Treatment of Tardive Dyskinesia With Galantamine (NCT00164242) | Caroff, Stanley N., M.D. | 2002-01-01 |
| Levetiracetam Treatment of Tardive Dyskinesia (NCT00291213) | Yale University | |